Ministry of Health Minister Chen Wei: "National Essential Drugs" Catalogue Will Expand

July 15, 2021

Three years have passed since the end of the three-year mandate of medical reform, and there are still some problems in the supply, tendering, and quantity of essential medicines.]

The three-year mission of medical reform has reached the end of the time limit, and the full coverage of the implementation of the basic drug system at the basic medical institutions has, although reducing the price of drugs to a certain extent, the people have received certain benefits, but the supply, tendering, and quantity of basic drug systems are all present. some problems.

On December 20, Minister of Health Chen Hao said at the National Pharmaceutical Supervision Conference: “The basic medical institutions organized by the government have now fully covered the basic medicine system, and other medical institutions will gradually fully deploy and give priority to the use of essential medicines. The National Essential Drug Directory should be further expanded to accommodate the use of drugs by all medical institutions."

Chen Hao said that the establishment of the basic drug system is an important task of the entire medical reform, and it is also a key link in the basic medical reform. In the next step, we will use the basic drug system as the starting point, and monitor the quality of the entire drug as an entry point to ensure that the essential drug quality is reliable, the price is reasonable, supply is timely, and it is safe and effective. The executive meeting of the State Council emphasizes that the production and supply capacity of the country’s essential drugs should be improved to ensure quality, safety, and fairness. It is necessary to strengthen basic drug sampling and tendering, procurement, and use of quality management, and improve the basic drug supply network and supervision network in rural areas. In particular, it is necessary to strengthen the supply of shortage drugs.

At the same time, he said that with regard to the reform of grass-roots medical and health institutions in the future, especially the reform of public hospitals in the next step, the basic medicine system is a reform that the public hospital reform cannot bypass.

However, the 307 kinds of basic drug systems formulated by the country have failed to meet the needs of the common people. What is more, we must face the reform of large-scale public hospitals.

Chen Hao said at the meeting that at present, China's overall pharmaceutical production capacity is in excess, but there are also some shortages of drugs, such as "orphan drugs", biological products, and blood products. This is a major issue involving the accessibility of medicines in China and is directly related to the completion of major tasks such as the establishment and improvement of the national essential medicine system.

“To expand the list of basic medicines, listing a list is very simple, but it poses great challenges for the inclusion of “orphan drugs,” blood, and biological products. For example, blood products and plasma are often in urgent need. These drugs are very I am very worried about being unable to guarantee supply.

Both plasma and immunoglobulins are medicines used to save lives, especially in critical care. Once they break their files, they will directly threaten their lives. Chen Yun said that certain types of essential drugs, orphan drugs, should be used. Certain blood products and biological products are subject to the national unified fixed-point production, unified tender procurement, unified distribution, and unified reserves, and fundamentally ensure supply.

At the same time, Chen Xi explained and doubted that “the implementation of unified production, uniform tendering and distribution of key drugs, and the establishment of a national drug reserve system are just some of the more concentrated ideas for some drugs in the pharmaceutical industry, and are not products of the planned economy.”

In addition, regarding the testing capabilities of the drug regulatory system, Chen Hao said: "Compared to the technical team of up to several thousand people owned by the U.S. FDA, China's Food and Drug Authentication Research Institute, which is responsible for the inspection and testing of related products such as pharmaceuticals and biological products, is only To 1,000 people, and in the detection of biological products, medical devices need urgent improvement." At the national food and drug supervision and management work conference, Chen Hao bluntly in his speech.

The national food and drug standards and effective detection issues have attracted much attention. Chen Hao said that the executive meeting of the State Council has determined that it is necessary to raise the national drug standards and improve the inspection and inspection system. We will strengthen the construction of national drug inspection agencies, improve laboratory conditions at the provincial and municipal (prefecture) level, and strengthen the rapid inspection capability of county-level institutions.

In recent years, medical science and technology are advancing with each passing day, and new medical treatments such as stem cell therapy are moving from the laboratory to the clinic. The "National Drug Safety Plan" regards "improving inspection and testing capabilities" as an important part. The next step in the direction of investment is not only to consider the improvement of local inspection and inspection capabilities, but also to increase investment in the Central Inspection Institute from both hardware and software aspects.

Surgical Drape

ShaoXing SurgeCare Medical Products Co., Ltd. , https://www.sxsurgecaremedical.com